Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma.
about
Quantification of fucosylated hemopexin and complement factor H in plasma of patients with liver diseaseAnalysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2011-2012.Intratumoral hepatic stellate cells as a poor prognostic marker and a new treatment target for hepatocellular carcinoma.In-depth mapping of the mouse brain N-glycoproteome reveals widespread N-glycosylation of diverse brain proteins.Enrichment of serum biomarkers by magnetic metal-organic framework composites.
P2860
Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Serum profiling based on fucos ...... and hepatocellular carcinoma.
@ast
Serum profiling based on fucos ...... and hepatocellular carcinoma.
@en
Serum profiling based on fucos ...... and hepatocellular carcinoma.
@nl
type
label
Serum profiling based on fucos ...... and hepatocellular carcinoma.
@ast
Serum profiling based on fucos ...... and hepatocellular carcinoma.
@en
Serum profiling based on fucos ...... and hepatocellular carcinoma.
@nl
prefLabel
Serum profiling based on fucos ...... and hepatocellular carcinoma.
@ast
Serum profiling based on fucos ...... and hepatocellular carcinoma.
@en
Serum profiling based on fucos ...... and hepatocellular carcinoma.
@nl
P2093
P1476
Serum profiling based on fucos ...... and hepatocellular carcinoma.
@en
P2093
Haihua Qian
Mengchao Wu
Ruixiu Zhang
Zhengfeng Yin
P304
P356
10.1016/J.BBRC.2012.02.155
P407
P577
2012-03-07T00:00:00Z